Anaphylaxis 1st Edition – PDF/EPUB Version Downloadable
Author(s): Gregory R. Bock; Jamie A. Goode
Publisher: Wiley-Blackwell
ISBN: 9780470861141
Edition: 1st Edition
$49,99
Delivery: This can be downloaded Immediately after purchasing.
Version: Only PDF Version.
Compatible Devices: Can be read on any device (Kindle, NOOK, Android/IOS devices, Windows, MAC)
Quality: High Quality. No missing contents. Printable
Recommended Software: Check here
Important: No Access Code
Description
Anaphylaxis is an immediate-type allergic reaction involving the whole organism. It is the most life-threatening allergic condition. Although there are few exact epidemiological data regarding prevalence, estimates regarding insect sting anaphylaxis range from 1-3% in the general population, but much higher values have been reported by some authors for food and drug-induced anaphylaxis. Anaphylaxis is the main acute killer of allergic individuals. Although anaphylaxis was discovered at the beginning of the 20th century, there are still many unresolved issues. These include non-IgE-mediated anaphylactoid reactions, non-immunologically mediated anaphylactoid (pseudo-allergic) reactions, pathophysiological events at the microcirculatory level, appropriate therapy for the acute reaction, strategies for prevention, public education about the problem and new approaches to prevention and therapy at the IgE level. All these subjects are discussed in this book. Since anaphylaxis occurs acutely and is unforeseen, it is very difficult to organize controlled studies regarding therapy and prevention. The spectrum of symptomatology covers many clinical areas (skin, respiratory, cardiovascular and gastrointestinal system), therefore inter-disciplinary approaches are necessary for progress in the field. There is widespread uncertainty among physicians about therapy, especially concerning self-administered treatment. In this important book, an multidisciplinary group of experts explore the pathophysiology of different types of anaphylactic and anaphylactoid reactions. Evidence is presented on the epidemiology of these conditions while problems relating to diagnosis, therapy and prevention are examined in detail. This thorough and up-to-date coverage of the subject will be of great interest to all clinical immunologists, researchers and physicians who deal with this life-threatening condition. Related Novartis Foundation symposia: 252 Generation and effector functions of regulatory lymphocytes Chair: Jean-François Bach Immunoinformatics: bioinformatic strategies for better understanding of immune function Chair: Hans-Georg Rammensee Cancer and inflammation Chair: Siamon Gordon
Related products
Anaphylaxis 1st Edition – PDF/EPUB Version Downloadable
Author(s):
Publisher: S. Karger AG (Switzerland)
ISBN: 9783805594417
Edition: 1st Edition
$49,99
Delivery: This can be downloaded Immediately after purchasing.
Version: Only PDF Version.
Compatible Devices: Can be read on any device (Kindle, NOOK, Android/IOS devices, Windows, MAC)
Quality: High Quality. No missing contents. Printable
Recommended Software: Check here
Important: No Access Code
Description
Anaphylaxis is the most dramatic and potentially life-threatening manifestation of an immediate-type hypersensitivity reaction. Although known for over 100 years, it still poses many unresolved questions, and its practical management and acute treatment are often more empiric in nature than evidence-based. In this book a multidisciplinary group of experts review the state of the art in the pathophysiology, epidemiology, diagnosis and clinical symptomatology of anaphylaxis. Its etiology with regard to different elicitors such as insect venoms, radiocontrast media, analgesics, general and local anesthetics is examined in detail. Finally, treatment modalities for anaphylaxis are discussed both for acute reactions and as general management recommendations for patients at risk. Providing thorough and up-to-date coverage of this frequently underestimated problem, this book is of interest not only to allergologists and immunologists, but also to all physicians and affected patients.

